Shares in Cenes surged 70 per cent yesterday after the developer of central nervous system drugs said it was in talks that may lead to an offer for the company.
The company's attraction is its experimental drug M6G, a post-operative pain treatment.
Cenes shares leap on takeover talks
By Salamander Davoudi
Published: February 6 2008 02:00 | Last updated: February 6 2008 02:00
You have viewed your allowance of free articles. If you wish to view more, click the button below.
